about
Heart-type fatty acid binding protein as an adjunct to cardiac troponin-I for the diagnosis of myocardial infarction.A Randomized Controlled Trial of Compression Rates during Cardiopulmonary Resuscitation.Differences in the Clinical Characteristics of Rapid Response System Activation in Patients Admitted to Medical or Surgical Services.Predicting change of hemoglobin after transfusion in hemodynamically stable anemic patients in emergency department.Rate of and risk factors for early recurrence in patients with febrile seizures.A simple model to predict bacteremia in women with acute pyelonephritis.Dose-dependent mortality and organ injury in a cecal slurry peritonitis model.ED crowding and the outcomes of out-of-hospital cardiac arrest.Effect of speed of rewarming and administration of anti-inflammatory or anti-oxidant agents on acute lung injury in an intestinal ischemia model treated with therapeutic hypothermia.Glutamine attenuates acute lung injury by inhibition of high mobility group box protein-1 expression during sepsis.The accuracy of emergency medicine and surgical residents in the diagnosis of acute appendicitis.Therapeutic hypothermia attenuates liver injury in polymicrobial sepsis model of rats via Akt survival pathway.Prognostic performance of diffusion-weighted MRI combined with NSE in comatose cardiac arrest survivors treated with mild hypothermia.Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.Effect of N-acetylcysteine (NAC) on acute lung injury and acute kidney injury in hemorrhagic shock.Effect of valproic acid on survival and neurologic outcomes in an asphyxial cardiac arrest model of rats.A risk stratification model of acute pyelonephritis to indicate hospital admission from the ED.Early norepinephrine infusion delays cardiac arrest after hemorrhagic shock in rats.The effect of ethyl pyruvate on dapsone-induced methemoglobinemia in rats.Gradual and stepwise increase of blood pressure in hemorrhagic shock: Mimicking ischemic post-conditioning.Protective effects of ethyl pyruvate treatment on paraquat-intoxicated rats.Blood pressure-targeted stepwise resuscitation for hemorrhagic shock in rats.Heart-type fatty acid-binding protein as a prognostic factor in patients with severe sepsis and septic shock.Blood pressure-targeted stepwise resuscitation of hemorrhagic shock in a swine model.A randomized comparison of nitrous oxide versus intravenous ketamine for laceration repair in children.Clinical effects of adjunctive atropine during ketamine sedation in pediatric emergency patients.Red cell distribution width is a prognostic factor in severe sepsis and septic shock.Red cell distribution width as a prognostic marker in patients with community-acquired pneumonia.Red blood cell distribution width as an independent predictor of all-cause mortality in out of hospital cardiac arrest.Bacteremia prediction model using a common clinical test in patients with community-acquired pneumonia.Risk stratification nomogram for nephropathy after abdominal contrast-enhanced computed tomography.The clinical significance of a failed initial intubation attempt during emergency department resuscitation of out-of-hospital cardiac arrest patients.Feasibility of continuous glucose monitoring in critically ill emergency department patients.Prognostic implication of initial coagulopathy in out-of-hospital cardiac arrestTherapeutic hypothermia attenuates acute lung injury in paraquat intoxication in ratsEffect of therapeutic hypothermia according to severity of sepsis in a septic rat modelDoes the quality of chest compressions deteriorate when the chest compression rate is above 120/min?Transcultural Adaptation and Validation of the Family Satisfaction in the Intensive Care Unit Questionnaire in a Korean SampleA membrane-tethering pepducin derived from formyl peptide receptor 3 shows strong therapeutic effects against sepsisModerate to severe hyperphosphataemia as an independent prognostic factor for 28-day mortality in adult patients with sepsis
P50
Q34451906-A8A34E2B-427D-4737-B1F7-E6D14F1E5C90Q37153239-0A2A6C72-5765-4D75-81DD-542860E3DFB2Q37677765-E0A972FE-6140-4BD3-877C-C1DFD966DF6DQ37692073-E6737EB3-89EF-4D06-8EBF-CFCFBE14DED4Q38233946-9E4DE8D1-EB5E-485E-A8D2-373C3B044C2DQ39989489-55835D7E-FEFD-4CAD-9466-6223D7821F10Q40437006-01E3DE56-0C50-4E75-9AC9-BAEA0731974FQ40589661-8B35C6A4-ED36-4AC9-BEB1-B1EBE3CA07DEQ43242227-317907EA-DCF2-430A-8E96-1D260AF0AAA2Q43262450-34BA4054-2744-4DF0-91CB-3B53939C49F4Q43524526-93F24C22-E957-4043-A398-6EBBDE12134AQ44037326-FB9EAE35-7D73-4A14-92FD-9AF01FCE737DQ44046151-ED186475-EE48-4068-9B2F-7E1B27DAD888Q44508552-95033E10-05A7-4E54-93C8-9CB26C652C22Q44785439-3BDC43F3-0ECE-4774-B336-1E8A84E5B4E8Q45820123-5773FC24-6D12-4227-A5B4-9727AD97D2BBQ45942028-BE24059C-B8B7-4743-8AF4-151371DFEA0EQ46189728-392FBDE7-A55D-4488-B77F-382E55436E33Q46343749-8C9AA10D-20C7-4800-A7AE-8434D88DB707Q46463020-8E944A89-320C-40AD-8105-DCFC60C7AC85Q46595796-96F74A11-CD49-4856-93B3-7946D56A16D0Q46929750-E57133BD-26EB-44A4-BB90-C44AC5229C33Q47960056-79CAE68F-56EC-4E19-BFBA-09807A2F3741Q48047611-B9017B4A-C7B0-4E35-BA1E-16DBF53CBB50Q48112110-A4935BE6-6532-41BC-91D6-349529E011F6Q48150518-2494E015-3B5D-484F-B7A9-366AEB43A288Q50495715-32396DE4-7DFD-40BF-89E1-728C168814D5Q50505701-34B51207-B8CA-42A8-9690-91ADAA8248D0Q50517399-E5559E75-FD1A-48A8-B6DF-19A5ADA40B67Q51831697-9E7C6B18-53EE-4BAD-AF2F-812C5CE5C39DQ53073497-4532E15E-6011-4711-B361-213A6E965122Q53297011-50BA7094-0678-48B8-A841-80CECD62AD5AQ53403111-6C43E61B-17AA-482D-AA8D-83A4CD281C9EQ58424659-D0C0E3F2-9920-4A71-85D9-8251C10F4B2EQ83209377-3B3D0885-9AB0-4CE3-B3F7-A0560A660CB1Q84974669-E8E427CD-F166-42E0-B0A4-9E7F2A80B281Q86848736-30A109D6-F8D5-4B8B-B649-4934C2B67158Q91273630-88CC29F9-6AF1-4C02-A650-353D26F4D056Q92941233-ED93D747-D005-4155-B163-6DF110B7CECDQ93161355-601CD646-9511-4B66-8982-F89241629E9F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
You Hwan Jo
@ast
You Hwan Jo
@en
You Hwan Jo
@es
You Hwan Jo
@nl
You Hwan Jo
@sl
type
label
You Hwan Jo
@ast
You Hwan Jo
@en
You Hwan Jo
@es
You Hwan Jo
@nl
You Hwan Jo
@sl
prefLabel
You Hwan Jo
@ast
You Hwan Jo
@en
You Hwan Jo
@es
You Hwan Jo
@nl
You Hwan Jo
@sl
P106
P1153
25822597600
P31
P496
0000-0002-9507-7603